# -Methylenedioxymethamphetamine (MDMA, Ecstasy) Induced Changes in Drug Metabolism: Gender and Genetic Polymorphisms

> **NCT01447472** · PHASE1 · COMPLETED · sponsor: **Parc de Salut Mar** · enrollment: 27 (actual)

## Conditions studied

- Metabolism
- Interaction

## Interventions

- **DRUG:** MDMA

## Key facts

- **NCT ID:** NCT01447472
- **Lead sponsor:** Parc de Salut Mar
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** 2009-05
- **Final completion:** 2011-05
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2011-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01447472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01447472, "-Methylenedioxymethamphetamine (MDMA, Ecstasy) Induced Changes in Drug Metabolism: Gender and Genetic Polymorphisms". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01447472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*